Listen to this page using ReadSpeaker

Delaware News



 Pages Tagged With: "Pfizer"

Weekly COVID-19 Update – February 18, 2022: Cases, Hospitalizations Continue Downward Trend

DOVER, DE (February 18, 2022) – The Delaware Division of Public Health (DPH) is providing an update on the most recent statistics related to coronavirus disease 2019 (COVID-19) in Delaware, as of Thursday, Feb 17, 2022. COVID-19 Cases and Hospitalizations:  Total positive cases since March 11, 2020: 254,719 7-day average of new positive cases: 232.6, a decrease […]




Weekly COVID-19 Update – Feb. 4, 2022: DPH Warns Against Complacency Amid Reduced Covid19 Cases

DOVER, DE (February 4, 2022) – The Delaware Division of Public Health (DPH) is providing an update on the most recent statistics related to coronavirus disease 2019 (COVID-19) in Delaware, as of Thursday, Feb 3, 2022. Although DPH reports decreasing data trends in hospitalization and new positive cases, it warns against complacency. Delawareans should continue to exercise […]




DPH Advises Vaccine Providers To Offer Booster Doses For All Three COVID-19 Vaccine Brands To Eligible Delawareans

The Delaware Division of Public Health announced that Delaware’s vaccine providers can begin administering booster doses for vaccines made by Moderna and Johnson & Johnson to certain populations that have been recommended by the Centers for Disease Control and Prevention (CDC). Pfizer-BioNTech’s COVID-19 vaccine received booster authorization last month. Any of the three authorized vaccines can be administered to qualifying individuals as a booster in a “mix and match” approach to the vaccine originally received.




Governors Jack Markell and Martin O’Malley Issue Joint Letters of Concern on Potential Acquisition of AstraZeneca

Governors Martin O’Malley (MD) and Jack Markell (DE) sent a letter to Ian Read, chairman and Chief Executive Officer of Pfizer, Inc., expressing deep concerns about the potential acquisition of AstraZeneca PLC.




Wyeth to pay $491 million to resolve allegations of off-label marketing of popular transplant drug

Biden’s office secures $111,000 recovery for Delaware’s Medicaid Program in national settlement







 Pages Tagged With: "Pfizer"

Weekly COVID-19 Update – February 18, 2022: Cases, Hospitalizations Continue Downward Trend

DOVER, DE (February 18, 2022) – The Delaware Division of Public Health (DPH) is providing an update on the most recent statistics related to coronavirus disease 2019 (COVID-19) in Delaware, as of Thursday, Feb 17, 2022. COVID-19 Cases and Hospitalizations:  Total positive cases since March 11, 2020: 254,719 7-day average of new positive cases: 232.6, a decrease […]




Weekly COVID-19 Update – Feb. 4, 2022: DPH Warns Against Complacency Amid Reduced Covid19 Cases

DOVER, DE (February 4, 2022) – The Delaware Division of Public Health (DPH) is providing an update on the most recent statistics related to coronavirus disease 2019 (COVID-19) in Delaware, as of Thursday, Feb 3, 2022. Although DPH reports decreasing data trends in hospitalization and new positive cases, it warns against complacency. Delawareans should continue to exercise […]




DPH Advises Vaccine Providers To Offer Booster Doses For All Three COVID-19 Vaccine Brands To Eligible Delawareans

The Delaware Division of Public Health announced that Delaware’s vaccine providers can begin administering booster doses for vaccines made by Moderna and Johnson & Johnson to certain populations that have been recommended by the Centers for Disease Control and Prevention (CDC). Pfizer-BioNTech’s COVID-19 vaccine received booster authorization last month. Any of the three authorized vaccines can be administered to qualifying individuals as a booster in a “mix and match” approach to the vaccine originally received.




Governors Jack Markell and Martin O’Malley Issue Joint Letters of Concern on Potential Acquisition of AstraZeneca

Governors Martin O’Malley (MD) and Jack Markell (DE) sent a letter to Ian Read, chairman and Chief Executive Officer of Pfizer, Inc., expressing deep concerns about the potential acquisition of AstraZeneca PLC.




Wyeth to pay $491 million to resolve allegations of off-label marketing of popular transplant drug

Biden’s office secures $111,000 recovery for Delaware’s Medicaid Program in national settlement